Antibiotic concerns highlight Skinbiotherapeutics' infections potential
The company has been developing products based around the skin portion of the human microbiome
Company
SkinBioTherapeutics PLC
LON:SBTX
SkinBioTherapeutics PLC is a life science company focused on skin health. The company’s proprietary platform technology, SkinBiotix ® , is based upon discoveries made at The University of Manchester.
156 stories · page 8 of 8
Archive
Proactive news snapshot: Rose Petroleum, Ortac Resources, SDX Energy …
A glance at some of the day's highlights from the Proactive Investors newswire
SSE rallies despite HSBC trimming its price target
SSE may have rallied, but Centrica remained down in the dumps, after HSBC trimmed its price target for the British Gas owner to 190p from 202p.
SkinBioTherapeutics results chart a year of significant progress
The SkinBiotix platform has been developed to enhance the skin cell barrier, protect the skin and aid its regeneration
FTSE 100 closes firmly in positive territory as sterling slides
The FTSE 100 rose to within a couple of points of 7,500 after US markets opened higher
Investments and investor services
Investors cautiously await DFS Furniture financials
DFS in August cautioned that earnings would be at the lower end of guidance.
Archive
Proactive news snapshot: Greatland Gold, Learning Technologies Group, SkinBioTherapeutics …
A glance at some of the day's highlights from the Proactive Investors newswire
Nighthawk Energy in breach of banking covenants
Nighthawk's bank has agreed to overlook the breach and Nighthawk is now considering its options. Meanwhile, Tristel has been hit by regulatory delays for a new product in the US
SkinBioTherapeutics PLC technology passes crucial milestone after independent test
Its SkinBiotix cream was assessed for cellular toxicity
FTSE 100 closes higher, boosted by weak sterling and Ferguson
The pound's weakness is the source of the Footsie's late strength
Archive
Tesco and Greggs to give a taste of high street conditions; hurricanes could have blown away US jobs
Week ahead to include first half results from supermarkets giant Tesco PLC, an update from high bakery chain Greggs PLC (LON:GRG), and the latest US jobs data
SkinBioTherapeutics: New listing in the emerging field of the human microbiome has multiple value trigger points
The company is based around the research on the skin microbiome by chief executive Dr Cath O’Neill and her team at Manchester University.
Materialising value for shareholders is the mantra for the boss of life sciences firm Optibiotix
Stephen O’Hara created Opti as a company all by himself in 2012 as a business focused on the rapidly growing microbiome space, which harnesses the positive benefits of microbes that live on the human body
Archive
Proactive news round-up: Strategic Minerals, Dekeloil Public, Rose Petroleum …
A glance at some of the stories on the Proactive newswire today
SkinBioTherapeutics makes storming AIM debut as shares rise 53%
The shares, listed at 9p each, were changing hands for 13.75p in early afternoon, valuing the business at a tad over £16mln.